# Ka‐Fai To

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ka-fai-to/

## Facts

| Field | Value |
| --- | --- |
| Citations | 50,466 |
| Field | RNA modifications and cancer |
| h-index | 120 |
| i10-index | 494 |
| Last Known Institution | Chinese University of Hong Kong |
| OpenAlex ID | https://openalex.org/A5050884242 |
| ORCID iD | https://orcid.org/0000-0003-4919-3707 |
| Works | 1,086 |

## Researcher papers

- [A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong](https://scholariq.org/papers/a-major-outbreak-of-severe-acute-respiratory-syndrome-in-hong-kong/)
- [Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)](https://scholariq.org/papers/biomarker-analyses-and-final-overall-survival-results-from-a-phase-iii/)
- [Acute renal impairment in coronavirus-associated severe acute respiratory syndrome](https://scholariq.org/papers/acute-renal-impairment-in-coronavirus-associated-severe-acute-respiratory/)
- [Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)](https://scholariq.org/papers/antitumor-activity-of-nivolumab-in-recurrent-and-metastatic-nasopharyngeal/)
- [Atrophy and intestinal metaplasia one year after cure of H. pylori infection: A prospective, randomized study](https://scholariq.org/papers/atrophy-and-intestinal-metaplasia-one-year-after-cure-of-h-pylori-infection-a/)
- [Multicenter, Phase II Study of Cetuximab in Combination With Carboplatin in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma](https://scholariq.org/papers/multicenter-phase-ii-study-of-cetuximab-in-combination-with-carboplatin-in/)
- [miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis](https://scholariq.org/papers/mir-375-is-involved-in-hippo-pathway-by-targeting-yap1-tead4-ctgf-axis-in/)
- [“Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy](https://scholariq.org/papers/interchangeability-of-pd-l1-immunohistochemistry-assays-a-meta-analysis-of/)
- [Gut microbiome dysbiosis across early Parkinson’s disease, REM sleep behavior disorder and their first-degree relatives](https://scholariq.org/papers/gut-microbiome-dysbiosis-across-early-parkinson-s-disease-rem-sleep-behavior/)

## Researcher topics

- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)
- [Cancer-related gene regulation](https://scholariq.org/topics/cancer-related-gene-regulation/)
- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)
- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)

## Researcher university

- [Chinese University of Hong Kong](https://scholariq.org/institutions/chinese-university-of-hong-kong/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.